Literature DB >> 34358138

Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans.

Aafke Aartse1,2, Dirk Eggink2, Mathieu Claireaux2, Sarah van Leeuwen2, Petra Mooij1, Willy M Bogers1, Rogier W Sanders2,3, Gerrit Koopman1, Marit J van Gils2.   

Abstract

Antibody responses against the influenza A virus hemagglutinin (HA)-protein are studied intensively because they can protect against (re)infection. Previous studies have focused on antibodies targeting the head or stem domains, while other possible specificities are often not taken into account. To study such specificities, we developed a diverse set of HA-domain proteins based on an H1N1pdm2009-like influenza virus strain, including monomeric head and trimeric stem domain, as well as the full HA-trimer. These proteins were used to study the B cell and antibody responses in six healthy human donors. A large proportion of HA-trimer B cells bound exclusively to HA-trimer probe (54-77%), while only 8-18% and 9-23% were able to recognize the stem or head probe, respectively. Monoclonal antibodies (mAbs) were isolated and three of these mAbs, targeting the different domains, were characterized in-depth to confirm the binding profile observed in flow cytometry. The head-directed mAb, targeting an epitope distinct from known head-specific mAbs, showed relatively broad H1N1 neutralization and the stem-directed mAb was able to broadly neutralize diverse H1N1 viruses. Moreover, we identified a trimer-directed mAb that did not compete with known head or stem domain specific mAbs, suggesting that it targets an unknown epitope or conformation of influenza virus' HA. These observations indicate that the described method can characterize the diverse antibody response to HA and might be able to identify HA-specific B cells and antibodies with previously unknown specificities that could be relevant for vaccine design.

Entities:  

Keywords:  antibody responses; head; hemagglutinin; influenza A virus; stem; trimer specific

Year:  2021        PMID: 34358138     DOI: 10.3390/vaccines9070717

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  5 in total

1.  Identifying vaccine escape sites via statistical comparisons of short-term molecular dynamics.

Authors:  Madhusudan Rajendran; Maureen C Ferran; Gregory A Babbitt
Journal:  Biophys Rep (N Y)       Date:  2022-04-04

2.  A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.

Authors:  Mathieu Claireaux; Tom G Caniels; Marlon de Gast; Julianna Han; Denise Guerra; Gius Kerster; Barbera D C van Schaik; Aldo Jongejan; Angela I Schriek; Marloes Grobben; Philip J M Brouwer; Karlijn van der Straten; Yoann Aldon; Joan Capella-Pujol; Jonne L Snitselaar; Wouter Olijhoek; Aafke Aartse; Mitch Brinkkemper; Ilja Bontjer; Judith A Burger; Meliawati Poniman; Tom P L Bijl; Jonathan L Torres; Jeffrey Copps; Isabel Cuella Martin; Steven W de Taeye; Godelieve J de Bree; Andrew B Ward; Kwinten Sliepen; Antoine H C van Kampen; Perry D Moerland; Rogier W Sanders; Marit J van Gils
Journal:  Nat Commun       Date:  2022-08-04       Impact factor: 17.694

3.  Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection.

Authors:  A H Ayesha Lavell; Jonne J Sikkens; Arthur W D Edridge; Karlijn van der Straten; Ferdyansyah Sechan; Melissa Oomen; David T P Buis; Michiel Schinkel; Judith A Burger; Meliawati Poniman; Jacqueline van Rijswijk; Menno D de Jong; Godelieve J de Bree; Edgar J G Peters; Yvo M Smulders; Rogier W Sanders; Marit J van Gils; Lia van der Hoek; Marije K Bomers
Journal:  iScience       Date:  2022-09-09

4.  Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic.

Authors:  Marloes Grobben; Hannah G Juncker; Karlijn van der Straten; A H Ayesha Lavell; Michiel Schinkel; David T P Buis; Maarten F Wilbrink; Khadija Tejjani; Mathieu A F Claireaux; Aafke Aartse; Christianne J M de Groot; Dasja Pajkrt; Marije K Bomers; Jonne J Sikkens; Marit J van Gils; Johannes B van Goudoever; Britt J van Keulen
Journal:  Microbiol Spectr       Date:  2022-06-28

5.  A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.

Authors:  Marit J van Gils; Hugo D G van Willigen; Elke Wynberg; Alvin X Han; Karlijn van der Straten; Judith A Burger; Meliawati Poniman; Melissa Oomen; Khadija Tejjani; Joey H Bouhuijs; Anouk Verveen; Romy Lebbink; Maartje Dijkstra; Brent Appelman; A H Ayesha Lavell; Tom G Caniels; Ilja Bontjer; Lonneke A van Vught; Alexander P J Vlaar; Jonne J Sikkens; Marije K Bomers; Colin A Russell; Neeltje A Kootstra; Rogier W Sanders; Maria Prins; Godelieve J de Bree; Menno D de Jong
Journal:  Cell Rep Med       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.